Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
HMS faculty, help us improve the algorithms in Profiles by
uploading your CV!
Return to Top
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Eur Respir J. 2012 Jul; 40(1):133-42.
View in:
PubMed
subject areas
Adolescent
Adult
Antitubercular Agents
Cohort Studies
Cost-Benefit Analysis
Estonia
Female
Health Care Costs
Humans
Male
Middle Aged
Quality-Adjusted Life Years
Russia
Treatment Outcome
Tuberculosis, Multidrug-Resistant
World Health Organization
Young Adult
authors with profiles
Salmaan A. Keshavjee, M.D., Ph.D.